Our first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
Read more
Our first patient has taken part in an interventional research trial testing potential treatments for people with severe COVID-19 infection, being cared for in an Intensive Care Unit.
Read more
Our first patient has taken part in the PRIEST study, a research trial aiming to optimise the triage of people using the emergency care system during the COVID-19 (coronavirus) pandemic.
Read more
The Kellgren Centre for Rheumatology at Manchester University NHS Foundation Trust (MFT) has won a national award for its work with patients with rheumatoid arthritis.
Read more
Staff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research
Read more
Our first patient has taken part in a research trial testing whether SNG001 – a drug treatment administered via a nebuliser – could be a potential treatment for COVID-19 (coronavirus).
Read more
MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.
Read more
A partnership of Manchester’s NHS and academic organisations will continue accelerating health research after once again receiving the prestigious Academic Health Science Centre (AHSC) designation.
Read more
